News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
166 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19345)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3995)
November (3760)
December (3171)
Day
1 (166)
2 (102)
3 (83)
7 (129)
8 (150)
9 (151)
10 (125)
11 (80)
14 (124)
15 (127)
16 (162)
17 (157)
18 (97)
21 (128)
22 (162)
23 (135)
24 (201)
25 (112)
28 (144)
29 (147)
30 (202)
31 (200)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
7
8
9
10
11
14
15
16
17
18
21
22
23
24
25
28
29
30
31
Drug Development
Specialty Vaccine Company PaxVax, Inc. Announces Positive Efficacy Results For Phase 3 Cholera Challenge Study
July 1, 2014
·
1 min read
Drug Development
GlycoMimetics, Inc. Announces Agreement With FDA On Special Protocol Assessment For Phase 3 Clinical Trial Of Rivipansel (GMI-1070)
July 1, 2014
·
1 min read
Drug Development
Agenus Brain Cancer Vaccine Shows Extended Survival In Phase 2 Final Data Analysis
July 1, 2014
·
1 min read
Deals
ANI Pharmaceuticals, Inc. Buys Lithobid Extended Release Tablets From Noven Therapeutics For $12 Million
July 1, 2014
·
4 min read
Policy
Vertex Pharmaceuticals (MA) Submits Supplemental New Drug Application (sNDA) To FDA For Use Of KALYDECO® (Ivacaftor) In People 18 And Older With Cystic Fibrosis Who Have The R117H Mutation
July 1, 2014
·
1 min read
Business
Avita Medical (ASX:AVH) New Chairman And Board Changes
July 1, 2014
·
3 min read
Business
CompaniondDx Reference Lab, LLC And Regenwell Holdings, LLC Partner To Provide World-Class Care To Patients
July 1, 2014
·
1 min read
Drug Development
Threshold Pharmaceuticals, Inc. Initiates 440-Patient, Randomized, Double-Blind, Placebo-Controlled Trial Of TH-302 In Combination With Pemetrexed In Advanced Non-Squamous Non-Small Cell Lung Cancer
July 1, 2014
·
7 min read
Biotech Beach
Sorrento Therapeutics, Inc. Awarded Up To $2.6 Million From The National Institutes of Health (NIH) For The Development Of New Anti-Bacterial Bispecific Antibodies And Antibody Formulated Drug Conjugates
July 1, 2014
·
4 min read
Business
Smithers Viscient Completes New Laboratory And European Headquarters
July 1, 2014
·
1 min read
Previous
9 of 17
Next
